Bank of New York Mellon
APYX icon

Bank of New York Mellon’s Apyx Medical APYX Stock Holding History

Bank of New York Mellon’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,683
Closed -$33.2K – 4161
2023
Q4 		$33.2K Hold
12,683
– – ﹤0.01% 4194
2023
Q3 		$40.6K Buy
12,683
+1
+0% +$5 ﹤0.01% 4182
2023
Q2 		$63.8K Sell
12,682
-8,068
-39% -$40.9K ﹤0.01% 4137
2023
Q1 		$59.8K Hold
20,750
– – ﹤0.01% 4167
2022
Q4 		$48.6K Hold
20,750
– – ﹤0.01% 4243
2022
Q3 		$93K Sell
20,750
-283
-1% -$2.03K ﹤0.01% 4210
2022
Q2 		$123K Sell
21,033
-79,331
-79% -$407K ﹤0.01% 4187
2022
Q1 		$656K Buy
100,364
+316
+0.3% +$3.11K ﹤0.01% 3554
2021
Q4 		$1.28M Buy
100,048
+5,908
+6% +$82.6K ﹤0.01% 3243
2021
Q3 		$1.3M Buy
94,140
+7,770
+9% +$81.7K ﹤0.01% 3246
2021
Q2 		$891K Sell
86,370
-22,347
-21% -$221K ﹤0.01% 3491
2021
Q1 		$1.05M Sell
108,717
-538
-0.5% -$5.38K ﹤0.01% 3305
2020
Q4 		$787K Sell
109,255
-4,289
-4% -$28.4K ﹤0.01% 3386
2020
Q3 		$534K Sell
113,544
-2,455
-2% -$12.2K ﹤0.01% 3458
2020
Q2 		$644K Buy
115,999
+4,827
+4% +$20.1K ﹤0.01% 3345
2020
Q1 		$399K Sell
111,172
-500
-0.4% -$3.36K ﹤0.01% 3483
2019
Q4 		$944K Buy
111,672
+580
+0.5% +$4.19K ﹤0.01% 3279
2019
Q3 		$753K Sell
111,092
-3,495
-3% -$24.8K ﹤0.01% 3326
2019
Q2 		$770K Buy
114,587
+91,133
+389% +$495K ﹤0.01% 3370
2019
Q1 		$148K Buy
23,454
+6,870
+41% +$53.1K ﹤0.01% 3941
2018
Q4 		$107K Buy
16,584
+1,445
+10% +$8.75K ﹤0.01% 3949
2018
Q3 		$107K Buy
+15,139
New +$84.1K ﹤0.01% 4030
2017
Q2 		– Sell
-13,144
Closed -$35K – 4295
2017
Q1 		$35K Buy
+13,144
New +$43.6K ﹤0.01% 4180

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCA
Greenwood Capital Associates Greenwood, South Carolina $1.02B AUM 28.26% 1-Year Est. Return

Bank of New York Mellon's APYX Position: Q1 2024 in Review

Bank of New York Mellon sold out of Apyx Medical (APYX) in Q1 2024, closing a stake of 12,683 shares — an estimated $33.2K sold.

Bank of New York Mellon first reported a position in APYX in Q1 2017 and held it in 23 quarters. The position peaked at $1.3M in Q3 2021. 51 funds tracked by Wall St. Rank hold APYX as of Q1 2024.

  • Bank of New York Mellon reported no remaining Apyx Medical position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 12,683 Apyx Medical shares in Q1 2024, an estimated $33.2K.
  • Bank of New York Mellon first reported a position in Apyx Medical in Q1 2017 and held it in 23 quarters.
  • Bank of New York Mellon's Apyx Medical position peaked at $1.3M in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.